Journal Article > ResearchFull Text
PLoS Curr. 2 February 2018; Volume 10; ecurrents.dis.bb5f22928e631dff9a80377309381feb.; DOI:10.1371/currents.dis.bb5f22928e631dff9a80377309381
Pereira AL, Southgate R, Ahmed H, Oconner P, Cramond V, et al.
PLoS Curr. 2 February 2018; Volume 10; ecurrents.dis.bb5f22928e631dff9a80377309381feb.; DOI:10.1371/currents.dis.bb5f22928e631dff9a80377309381
In 2015, following an influx of population into Kobanê in northern Syria, Médecins Sans Frontières (MSF) in collaboration with the Kobanê Health Administration (KHA) initiated primary healthcare activities. A vaccination coverage survey and vaccine-preventable disease (VPD) risk analysis were undertaken to clarify the VPD risk and vaccination needs. This was followed by a measles Supplementary Immunization Activity (SIA). We describe the methods and results used for this prioritisation activity around vaccination in Kobanê in 2015.
Journal Article > ResearchFull Text
BMC Public Health. 11 April 2013; Volume 13 (Issue 1); DOI:10.1186/1471-2458-13-332
van den Bogaart E, Berkhout MMZ, Nour AB, Mens PF, Talha AA, et al.
BMC Public Health. 11 April 2013; Volume 13 (Issue 1); DOI:10.1186/1471-2458-13-332
In areas where visceral leishmaniasis (VL) and malaria are co-endemic, co-infections are common. Clinical implications range from potential diagnostic delay to increased disease-related morbidity, as compared to VL patients. Nevertheless, public awareness of the disease remains limited. In VL-endemic areas with unstable and seasonal malaria, vulnerability to the disease persists through all age-groups, suggesting that in these populations, malaria may easily co-occur with VL, with potentially severe clinical effects.